Cargando…
Issuing bonds during the Covid-19 pandemic: Was there an ESG premium?()
We rely on the ESG ratings assigned by four distinct agencies (MSCI, Refinitiv, Robeco, and Sustainalytics) to study the link between ESG scores and firms’ cost of debt financing during the Covid-19 pandemic. We document the existence of a statistically and economically significant ESG premium, i.e....
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098047/ https://www.ncbi.nlm.nih.gov/pubmed/37070084 http://dx.doi.org/10.1016/j.irfa.2023.102653 |
_version_ | 1785024709740462080 |
---|---|
author | Ferriani, Fabrizio |
author_facet | Ferriani, Fabrizio |
author_sort | Ferriani, Fabrizio |
collection | PubMed |
description | We rely on the ESG ratings assigned by four distinct agencies (MSCI, Refinitiv, Robeco, and Sustainalytics) to study the link between ESG scores and firms’ cost of debt financing during the Covid-19 pandemic. We document the existence of a statistically and economically significant ESG premium, i.e. better rated companies access debt at a lower cost. Despite some differences across rating agencies, this result is robust to additional controls for the issuer’s credit standing as well as several bond and issuer’s characteristics. We find that this effect is mainly driven by firms domiciled in advanced economies, whereas creditworthiness considerations prevail for firms in emerging markets. Lastly, we show that the lower cost of capital for highly rated ESG firms is explained both by investors’ preference for more sustainable assets and by risk-based considerations unrelated to firms’ creditworthiness, such as exposure to climate change risks. |
format | Online Article Text |
id | pubmed-10098047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100980472023-04-13 Issuing bonds during the Covid-19 pandemic: Was there an ESG premium?() Ferriani, Fabrizio Int Rev Financ Anal Article We rely on the ESG ratings assigned by four distinct agencies (MSCI, Refinitiv, Robeco, and Sustainalytics) to study the link between ESG scores and firms’ cost of debt financing during the Covid-19 pandemic. We document the existence of a statistically and economically significant ESG premium, i.e. better rated companies access debt at a lower cost. Despite some differences across rating agencies, this result is robust to additional controls for the issuer’s credit standing as well as several bond and issuer’s characteristics. We find that this effect is mainly driven by firms domiciled in advanced economies, whereas creditworthiness considerations prevail for firms in emerging markets. Lastly, we show that the lower cost of capital for highly rated ESG firms is explained both by investors’ preference for more sustainable assets and by risk-based considerations unrelated to firms’ creditworthiness, such as exposure to climate change risks. Elsevier Inc. 2023-07 2023-04-13 /pmc/articles/PMC10098047/ /pubmed/37070084 http://dx.doi.org/10.1016/j.irfa.2023.102653 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ferriani, Fabrizio Issuing bonds during the Covid-19 pandemic: Was there an ESG premium?() |
title | Issuing bonds during the Covid-19 pandemic: Was there an ESG premium?() |
title_full | Issuing bonds during the Covid-19 pandemic: Was there an ESG premium?() |
title_fullStr | Issuing bonds during the Covid-19 pandemic: Was there an ESG premium?() |
title_full_unstemmed | Issuing bonds during the Covid-19 pandemic: Was there an ESG premium?() |
title_short | Issuing bonds during the Covid-19 pandemic: Was there an ESG premium?() |
title_sort | issuing bonds during the covid-19 pandemic: was there an esg premium?() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098047/ https://www.ncbi.nlm.nih.gov/pubmed/37070084 http://dx.doi.org/10.1016/j.irfa.2023.102653 |
work_keys_str_mv | AT ferrianifabrizio issuingbondsduringthecovid19pandemicwasthereanesgpremium |